[
  {
    "ts": "2025-10-30T22:00:00+00:00",
    "headline": "The Day Pharma’s Weight-Loss Gold Rush Intensified",
    "summary": "Lilly’s quarterly results Thursday, combined with Novo Nordisk’s unsolicited offer for a startup, confirm the $72 billion anti-obesity market is among pharma’s hottest.",
    "url": "https://www.wsj.com/health/pharma/the-day-pharmas-weight-loss-gold-rush-intensified-c5c32c11?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "aae004de-35f0-3aee-9e24-c1babeef0f5a",
      "content": {
        "id": "aae004de-35f0-3aee-9e24-c1babeef0f5a",
        "contentType": "STORY",
        "title": "The Day Pharma’s Weight-Loss Gold Rush Intensified",
        "description": "",
        "summary": "Lilly’s quarterly results Thursday, combined with Novo Nordisk’s unsolicited offer for a startup, confirm the $72 billion anti-obesity market is among pharma’s hottest.",
        "pubDate": "2025-10-30T22:00:00Z",
        "displayTime": "2025-10-30T22:00:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/aae004de-35f0-3aee-9e24-c1babeef0f5a/the-day-pharma%E2%80%99s-weight-loss.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/d4b7c151d9a6e4d25d278676ed6aa40b",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7TZDpRhAhYrNQzokQP1zSw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/d4b7c151d9a6e4d25d278676ed6aa40b.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GQFOyhHOX1fELsmsJAFP0A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/d4b7c151d9a6e4d25d278676ed6aa40b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/the-day-pharmas-weight-loss-gold-rush-intensified-c5c32c11?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T21:23:00+00:00",
    "headline": "Health Care Roundup: Market Talk",
    "summary": "1329 ET – Eli Lilly’s direct channel sales are reducing obstacles to access GLP-1 drugs, helping it grow the total market, the company says on its analyst call.  “There is significant demand in the consumer segment related to finding ways to get outside some of the frictions in the health care system,” Lily USA President  Ilya Yuffa  says.  “We’re seeing significantly more volume go through a direct-to-consumer platform with Lilly Direct.”",
    "url": "https://www.wsj.com/health/health-care-roundup-market-talk-65f26e3f?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "8d6b1c09-aea3-36e9-96a9-3d6ae15bcfb5",
      "content": {
        "id": "8d6b1c09-aea3-36e9-96a9-3d6ae15bcfb5",
        "contentType": "STORY",
        "title": "Health Care Roundup: Market Talk",
        "description": "",
        "summary": "1329 ET – Eli Lilly’s direct channel sales are reducing obstacles to access GLP-1 drugs, helping it grow the total market, the company says on its analyst call.  “There is significant demand in the consumer segment related to finding ways to get outside some of the frictions in the health care system,” Lily USA President  Ilya Yuffa  says.  “We’re seeing significantly more volume go through a direct-to-consumer platform with Lilly Direct.”",
        "pubDate": "2025-10-30T21:23:00Z",
        "displayTime": "2025-10-30T21:23:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/8d6b1c09-aea3-36e9-96a9-3d6ae15bcfb5/health-care-roundup-market.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/584f487d9febfcdcb9dec8d0905b588d",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7C8N0J6U82R5zJhMhfEY2g--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/584f487d9febfcdcb9dec8d0905b588d.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Gox2xigzu11PPu88Phespw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/584f487d9febfcdcb9dec8d0905b588d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/health-care-roundup-market-talk-65f26e3f?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "WMT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T20:52:03+00:00",
    "headline": "Stock Market Today: Nasdaq, S&P End Sharply Lower With Meta's Plunge",
    "summary": "Stock Market Today: The Dow Jones index rises while the Nasdaq drops with Meta stock plunging. Chipotle sinks.",
    "url": "https://www.investors.com/market-trend/stock-market-today/stock-market-today-trump-xi-talks-meta-stock/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "feaa48e6-1655-3345-8855-6400897140af",
      "content": {
        "id": "feaa48e6-1655-3345-8855-6400897140af",
        "contentType": "STORY",
        "title": "Stock Market Today: Nasdaq, S&P End Sharply Lower With Meta's Plunge",
        "description": "",
        "summary": "Stock Market Today: The Dow Jones index rises while the Nasdaq drops with Meta stock plunging. Chipotle sinks.",
        "pubDate": "2025-10-30T20:52:03Z",
        "displayTime": "2025-10-30T20:52:03Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/feaa48e6-1655-3345-8855-6400897140af/stock-market-today-nasdaq-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/55ca4252bd7c66820fc61ce444908e68",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RkIoP5aIoaWmMg1KUnpqdg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/55ca4252bd7c66820fc61ce444908e68.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Wh39EUbEziJHgMn.DZRyfQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/55ca4252bd7c66820fc61ce444908e68.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/stock-market-today-trump-xi-talks-meta-stock/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "CMG"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "META"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T20:35:47+00:00",
    "headline": "Stocks to Watch Thursday Recap: Eli Lilly, Metsera, Navan, Chipotle",
    "summary": "↘️ Chipotle Mexican Grill (CMG): The restaurant chain posted a drop in net income and quarterly revenue missed forecasts. Chipotle said economic strains were turning customers away from its stores. Shares slid 18% Thursday.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-10-30-2025/card/stocks-to-watch-thursday-meta-alphabet-chipotle-zOcn5pYgY3Q0CShd1zKT?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "7ebd3083-9d92-3704-bb74-087511f7b97b",
      "content": {
        "id": "7ebd3083-9d92-3704-bb74-087511f7b97b",
        "contentType": "STORY",
        "title": "Stocks to Watch Thursday Recap: Eli Lilly, Metsera, Navan, Chipotle",
        "description": "",
        "summary": "↘️ Chipotle Mexican Grill (CMG): The restaurant chain posted a drop in net income and quarterly revenue missed forecasts. Chipotle said economic strains were turning customers away from its stores. Shares slid 18% Thursday.",
        "pubDate": "2025-10-30T20:35:47Z",
        "displayTime": "2025-10-30T20:35:47Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/7ebd3083-9d92-3704-bb74-087511f7b97b/stocks-to-watch-thursday.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/02bb6f992d92efe9603e55c2990c116d",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oQNGO6eehy5n6P4CNMHq9Q--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/02bb6f992d92efe9603e55c2990c116d.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kuiQZYF7yEnjK6dUfh1K5g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/02bb6f992d92efe9603e55c2990c116d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-10-30-2025/card/stocks-to-watch-thursday-meta-alphabet-chipotle-zOcn5pYgY3Q0CShd1zKT?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CMG"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T20:15:48+00:00",
    "headline": "Eli Lilly Smashes Expectations In 'Arguably The Strongest Print' Of The Quarter",
    "summary": "Eli Lilly stock rose early Thursday after the drugmaker easily topped third-quarter forecasts on the back of its two biggest drugs.",
    "url": "https://www.investors.com/news/technology/eli-lilly-stock-eli-lilly-earnings-q3-2025/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "b9b06bf3-b8d6-38f0-8e32-9ea150bcdb38",
      "content": {
        "id": "b9b06bf3-b8d6-38f0-8e32-9ea150bcdb38",
        "contentType": "STORY",
        "title": "Eli Lilly Smashes Expectations In 'Arguably The Strongest Print' Of The Quarter",
        "description": "",
        "summary": "Eli Lilly stock rose early Thursday after the drugmaker easily topped third-quarter forecasts on the back of its two biggest drugs.",
        "pubDate": "2025-10-30T20:15:48Z",
        "displayTime": "2025-10-30T20:15:48Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/b9b06bf3-b8d6-38f0-8e32-9ea150bcdb38/eli-lilly-smashes.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/67464aa2598bc109a3cce706482c0735",
          "originalWidth": 1012,
          "originalHeight": 572,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/45lZaPmm8vZHt8t16Pv3Sw--~B/aD01NzI7dz0xMDEyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/67464aa2598bc109a3cce706482c0735.cf.webp",
              "width": 1012,
              "height": 572,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zVkqSTYjINnOUb2UYhN_og--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/67464aa2598bc109a3cce706482c0735.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/eli-lilly-stock-eli-lilly-earnings-q3-2025/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T20:09:15+00:00",
    "headline": "Novo Nordisk Kicks Off Bloody Battle With Pfizer, Bidding $6.5 Billion On Metsera",
    "summary": "Novo Nordisk kicked off a battle with Pfizer on Thursday, making an unsolicited $6.5 billion bid for obesity-focused Metsera.",
    "url": "https://www.investors.com/news/technology/metsera-novo-nordisk-pfizer-acquisition/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "3613926f-5ec1-3045-ac4f-004ea3b1dc9d",
      "content": {
        "id": "3613926f-5ec1-3045-ac4f-004ea3b1dc9d",
        "contentType": "STORY",
        "title": "Novo Nordisk Kicks Off Bloody Battle With Pfizer, Bidding $6.5 Billion On Metsera",
        "description": "",
        "summary": "Novo Nordisk kicked off a battle with Pfizer on Thursday, making an unsolicited $6.5 billion bid for obesity-focused Metsera.",
        "pubDate": "2025-10-30T20:09:15Z",
        "displayTime": "2025-10-30T20:09:15Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/3613926f-5ec1-3045-ac4f-004ea3b1dc9d/novo-nordisk-kicks-off-bloody.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/46c18cf5ac864a5f2306cbef485a793d",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bgU9bQx8PEX1hmzKGf7SUQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/46c18cf5ac864a5f2306cbef485a793d.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hKX7h7M6laSMqhtIrlgfyA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/46c18cf5ac864a5f2306cbef485a793d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/metsera-novo-nordisk-pfizer-acquisition/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T18:30:00+00:00",
    "headline": "Eli Lilly teams up with Walmart on Zepbound: CFO explains",
    "summary": "Eli Lilly (LLY) stock rises after reporting that sales of its weight-loss drugs more than doubled in the third quarter. The pharmaceutical company also announced a partnership with Walmart (WMT) to make GLP-1s more accessible to consumers. Eli Lilly CFO Lucas Montarce joins Market Catalysts to discuss the pharmaceutical giant's earnings print and its Walmart partnership. To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Catalysts.",
    "url": "https://finance.yahoo.com/video/eli-lilly-teams-walmart-zepbound-183000949.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "a5f4242e-59ff-3786-a8b0-d53e14cdc1ed",
      "content": {
        "id": "a5f4242e-59ff-3786-a8b0-d53e14cdc1ed",
        "contentType": "VIDEO",
        "title": "Eli Lilly teams up with Walmart on Zepbound: CFO explains",
        "description": "<p>Eli Lilly (<a data-i13n=\"cpos:1;pos:1\" href=\"https://finance.yahoo.com/quote/LLY\">LLY</a>) stock rises after reporting that sales of its weight-loss drugs more than doubled in the third quarter. The pharmaceutical company also announced a <a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/news/lillydirect-walmart-pharmacy-launch-first-110000681.html\">partnership with Walmart</a> (<a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/quote/WMT\">WMT</a>) to make GLP-1s more accessible to consumers.</p>\n<p>Eli Lilly CFO Lucas Montarce joins Market Catalysts to discuss the pharmaceutical giant's earnings print and its Walmart partnership.</p>\n<p>To watch more expert insights and analysis on the latest market action, check out more <a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/videos/series/market-catalysts/\">Market Catalysts</a>.</p>",
        "summary": "Eli Lilly (LLY) stock rises after reporting that sales of its weight-loss drugs more than doubled in the third quarter. The pharmaceutical company also announced a partnership with Walmart (WMT) to make GLP-1s more accessible to consumers. Eli Lilly CFO Lucas Montarce joins Market Catalysts to discuss the pharmaceutical giant's earnings print and its Walmart partnership. To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Catalysts.",
        "pubDate": "2025-10-30T18:30:00Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-10/11b607f0-b5ac-11f0-bbff-f4c1f07ef4ae",
          "originalWidth": 5192,
          "originalHeight": 2918,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Zq6i0h3xfEOdt8U7OeAA3w--~B/aD0yOTE4O3c9NTE5MjthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-10/11b607f0-b5ac-11f0-bbff-f4c1f07ef4ae.cf.webp",
              "width": 5192,
              "height": 2918,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pOkqkUQSa_E5X28DfxT.5g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-10/11b607f0-b5ac-11f0-bbff-f4c1f07ef4ae.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/eli-lilly-teams-walmart-zepbound-183000949.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/eli-lilly-teams-walmart-zepbound-183000949.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WMT"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T18:11:00+00:00",
    "headline": "Novo Nordisk Tries to Snatch a Weight-Loss Biotech From Pfizer. There Are Political Risks.",
    "summary": "Denmark’s Novo offers $56.50 a share in cash for Metsera, plus potentially a further $21.25 a share based on clinical and regulatory milestones.",
    "url": "https://www.barrons.com/articles/metsera-stock-price-novo-nordisk-pfizer-c4d11ef3?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "bd906d23-4a54-3aa1-aef9-345da8a1bdcd",
      "content": {
        "id": "bd906d23-4a54-3aa1-aef9-345da8a1bdcd",
        "contentType": "STORY",
        "title": "Novo Nordisk Tries to Snatch a Weight-Loss Biotech From Pfizer. There Are Political Risks.",
        "description": "",
        "summary": "Denmark’s Novo offers $56.50 a share in cash for Metsera, plus potentially a further $21.25 a share based on clinical and regulatory milestones.",
        "pubDate": "2025-10-30T18:11:00Z",
        "displayTime": "2025-10-30T18:11:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/bd906d23-4a54-3aa1-aef9-345da8a1bdcd/novo-nordisk-tries-to-snatch.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/019f884130a6e200476be84a3ab8457a",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZSFoYvCd8e.k8vl3TWvLsg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/019f884130a6e200476be84a3ab8457a.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gOhtizi3tDMbrEr9yGeQEA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/019f884130a6e200476be84a3ab8457a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/metsera-stock-price-novo-nordisk-pfizer-c4d11ef3?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T17:50:42+00:00",
    "headline": "Eli Lilly (LLY) Stock Trades Up, Here Is Why",
    "summary": "Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.1% in the morning session after the company reported a \"beat and raise\" quarter.",
    "url": "https://finance.yahoo.com/news/eli-lilly-lly-stock-trades-175042084.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "19834b68-8d6c-3ec6-86ee-58bfe7acfeff",
      "content": {
        "id": "19834b68-8d6c-3ec6-86ee-58bfe7acfeff",
        "contentType": "STORY",
        "title": "Eli Lilly (LLY) Stock Trades Up, Here Is Why",
        "description": "",
        "summary": "Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.1% in the morning session after the company reported a \"beat and raise\" quarter.",
        "pubDate": "2025-10-30T17:50:42Z",
        "displayTime": "2025-10-30T17:50:42Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/2d0b545c448821f8d1ada0dbe955b186",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "LLY Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/y7jUkGcVljBpqcrgSnimZQ--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/2d0b545c448821f8d1ada0dbe955b186.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fw6rZdJZ6CRFkLxhDmPhew--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/2d0b545c448821f8d1ada0dbe955b186.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-lly-stock-trades-175042084.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-lly-stock-trades-175042084.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T17:31:05+00:00",
    "headline": "Bidding war rises over weight loss drug that could prevent ‘Ozempic face’",
    "summary": "Two of the world’s largest pharmaceutical companies are locked in a bidding war for the maker of a weight-loss drug that could help patients avoid succumbing to “Ozempic face”.",
    "url": "https://uk.finance.yahoo.com/news/bidding-war-rises-over-weight-173105753.html",
    "source": "The Telegraph",
    "provider": "yfinance",
    "raw": {
      "id": "2c42fd54-a8c8-3470-876f-d513e29217f2",
      "content": {
        "id": "2c42fd54-a8c8-3470-876f-d513e29217f2",
        "contentType": "STORY",
        "title": "Bidding war rises over weight loss drug that could prevent ‘Ozempic face’",
        "description": "",
        "summary": "Two of the world’s largest pharmaceutical companies are locked in a bidding war for the maker of a weight-loss drug that could help patients avoid succumbing to “Ozempic face”.",
        "pubDate": "2025-10-30T17:31:05Z",
        "displayTime": "2025-10-30T17:31:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/the_telegraph_818/64ac1bd7d34fa43d6cd2df105ebe47dd",
          "originalWidth": 2500,
          "originalHeight": 1563,
          "caption": "Novo Nordisk headquarters in Bagsvaerd, Denmark",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qFAQWoPq.RMLDIn7IKXc1A--~B/aD0xNTYzO3c9MjUwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/the_telegraph_818/64ac1bd7d34fa43d6cd2df105ebe47dd.cf.webp",
              "width": 2500,
              "height": 1563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tUC2RpSoPjG5Y2JTgOwMIA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/the_telegraph_818/64ac1bd7d34fa43d6cd2df105ebe47dd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Telegraph",
          "url": "http://www.telegraph.co.uk/"
        },
        "canonicalUrl": {
          "url": "https://uk.finance.yahoo.com/news/bidding-war-rises-over-weight-173105753.html",
          "site": "finance",
          "region": "GB",
          "lang": "en-GB"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bidding-war-rises-over-weight-173105753.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T17:10:03+00:00",
    "headline": "Nvidia & Eli Lilly supercomputer will 'accelerate' drug discovery",
    "summary": "Eli Lilly (LLY) is one of Nvidia's (NVDA) many partners announced by the artificial intelligence (AI) chipmaker. The two companies are teaming up to build a supercomputer for drug discovery. Eli Lilly CFO, Lucas Montarce, explains how the partnership will help the pharmaceutical company grow. To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Catalysts.",
    "url": "https://finance.yahoo.com/video/nvidia-eli-lilly-supercomputer-accelerate-171003556.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "e974addd-85a4-324e-929e-dea7b5692b11",
      "content": {
        "id": "e974addd-85a4-324e-929e-dea7b5692b11",
        "contentType": "VIDEO",
        "title": "Nvidia & Eli Lilly supercomputer will 'accelerate' drug discovery",
        "description": "<p>Eli Lilly (<a data-i13n=\"cpos:1;pos:1\" href=\"https://finance.yahoo.com/quote/LLY\">LLY</a>) is one of Nvidia's (<a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/quote/NVDA\">NVDA</a>) many partners announced by the artificial intelligence (AI) chipmaker. The two companies are teaming up to build a supercomputer for drug discovery.</p>\n<p>Eli Lilly CFO, Lucas Montarce, explains how the partnership will help the pharmaceutical company grow.</p>\n<p>To watch more expert insights and analysis on the latest market action, check out more <a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/videos/series/market-catalysts/\">Market Catalysts</a>.</p>",
        "summary": "Eli Lilly (LLY) is one of Nvidia's (NVDA) many partners announced by the artificial intelligence (AI) chipmaker. The two companies are teaming up to build a supercomputer for drug discovery. Eli Lilly CFO, Lucas Montarce, explains how the partnership will help the pharmaceutical company grow. To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Catalysts.",
        "pubDate": "2025-10-30T17:10:03Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-10/a9e77d30-b5af-11f0-bbff-3250acf93962",
          "originalWidth": 4000,
          "originalHeight": 2252,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nKbSchSrcvIdZOuMyZ43kQ--~B/aD0yMjUyO3c9NDAwMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-10/a9e77d30-b5af-11f0-bbff-3250acf93962.cf.webp",
              "width": 4000,
              "height": 2252,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Z53JktPdwKiSbIiZpTW6xQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-10/a9e77d30-b5af-11f0-bbff-3250acf93962.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/nvidia-eli-lilly-supercomputer-accelerate-171003556.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/nvidia-eli-lilly-supercomputer-accelerate-171003556.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T16:57:00+00:00",
    "headline": "Lilly Beats on Q3 Earnings, Ups View, Mounjaro, Zepbound Drive Sales",
    "summary": "Lilly tops Q3 estimates as Mounjaro and Zepbound fuel a 54% revenue surge, prompting the drugmaker to raise its full-year sales and earnings outlook.",
    "url": "https://finance.yahoo.com/news/lilly-beats-q3-earnings-ups-165700217.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "8eb81898-5c9a-3083-803b-df84f6aecbb0",
      "content": {
        "id": "8eb81898-5c9a-3083-803b-df84f6aecbb0",
        "contentType": "STORY",
        "title": "Lilly Beats on Q3 Earnings, Ups View, Mounjaro, Zepbound Drive Sales",
        "description": "",
        "summary": "Lilly tops Q3 estimates as Mounjaro and Zepbound fuel a 54% revenue surge, prompting the drugmaker to raise its full-year sales and earnings outlook.",
        "pubDate": "2025-10-30T16:57:00Z",
        "displayTime": "2025-10-30T16:57:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MjuR.4zEKm0FgKsxK.lBKQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/G.VCDKzJSEg_sv.1sSAJrQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/lilly-beats-q3-earnings-ups-165700217.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lilly-beats-q3-earnings-ups-165700217.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "BAYRY"
            },
            {
              "symbol": "BAYZF"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T16:12:15+00:00",
    "headline": "Eli Lilly Stock Rises -- Blowout Earnings Smash Forecasts, Lifts 2025 Outlook",
    "summary": "Massive Earnings Surprise Sends Eli Lilly Stock Higher",
    "url": "https://finance.yahoo.com/news/eli-lilly-stock-rises-blowout-161215342.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "8bb327ce-d2c2-3fc0-a457-3a719a9cf601",
      "content": {
        "id": "8bb327ce-d2c2-3fc0-a457-3a719a9cf601",
        "contentType": "STORY",
        "title": "Eli Lilly Stock Rises -- Blowout Earnings Smash Forecasts, Lifts 2025 Outlook",
        "description": "",
        "summary": "Massive Earnings Surprise Sends Eli Lilly Stock Higher",
        "pubDate": "2025-10-30T16:12:15Z",
        "displayTime": "2025-10-30T16:12:15Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/d0b2925021ba921981c34cbf188ac66c",
          "originalWidth": 500,
          "originalHeight": 500,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8b14zxH4BANQFraIfqB7ug--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/d0b2925021ba921981c34cbf188ac66c.cf.webp",
              "width": 500,
              "height": 500,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/j_oIKXponyFLhltsjvcwTQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/d0b2925021ba921981c34cbf188ac66c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-stock-rises-blowout-161215342.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-stock-rises-blowout-161215342.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T15:10:00+00:00",
    "headline": "Earnings Data Deluge",
    "summary": "Earnings Data Deluge",
    "url": "https://finance.yahoo.com/news/earnings-data-deluge-151000270.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "62011ba0-3065-31d1-b9b0-bdc16a03353a",
      "content": {
        "id": "62011ba0-3065-31d1-b9b0-bdc16a03353a",
        "contentType": "STORY",
        "title": "Earnings Data Deluge",
        "description": "",
        "summary": "Earnings Data Deluge",
        "pubDate": "2025-10-30T15:10:00Z",
        "displayTime": "2025-10-30T15:10:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/0ffd39459c74599bc0fe12d9c52f7640",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/arqfU.zSuZeRYqiyCocsAg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0ffd39459c74599bc0fe12d9c52f7640.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/j4nh8jwfgZz9PEXQtb2xZQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0ffd39459c74599bc0fe12d9c52f7640.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/earnings-data-deluge-151000270.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/earnings-data-deluge-151000270.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MA"
            },
            {
              "symbol": "EL"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T14:39:12+00:00",
    "headline": "Obesity, diabetes treatments fuel Eli Lilly growth and spark bidding war",
    "summary": "Lilly said Thursday that its top-selling drugs, Mounjaro and Zepbound, brought in more than $10 billion combined during the recently completed third quarter.  Separately, Danish drugmaker Novo Nordisk announced plans to buy Metsera Inc. in a deal that could be worth up to $9 billion.",
    "url": "https://finance.yahoo.com/news/obesity-diabetes-treatments-fuel-eli-143912326.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "f7cfd522-2daf-3e44-9bc7-4d4c4643c565",
      "content": {
        "id": "f7cfd522-2daf-3e44-9bc7-4d4c4643c565",
        "contentType": "STORY",
        "title": "Obesity, diabetes treatments fuel Eli Lilly growth and spark bidding war",
        "description": "",
        "summary": "Lilly said Thursday that its top-selling drugs, Mounjaro and Zepbound, brought in more than $10 billion combined during the recently completed third quarter.  Separately, Danish drugmaker Novo Nordisk announced plans to buy Metsera Inc. in a deal that could be worth up to $9 billion.",
        "pubDate": "2025-10-30T14:39:12Z",
        "displayTime": "2025-10-30T14:39:12Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ap_finance_articles_694/406134abb585ddf93c2258b0ae260dc9",
          "originalWidth": 8640,
          "originalHeight": 5760,
          "caption": "FILE - This photo shows Novo Nordisk headquarters in Bagsvaerd, Denmark, on Feb. 5, 2025. (Mads Claus Rasmussen/Ritzau Scanpix via AP, File)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kmeBfzTm_TvuIjA7hbDxhw--~B/aD01NzYwO3c9ODY0MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/ap_finance_articles_694/406134abb585ddf93c2258b0ae260dc9.cf.webp",
              "width": 8640,
              "height": 5760,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8_GyHhE_8BDGhHKyfFnJaA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ap_finance_articles_694/406134abb585ddf93c2258b0ae260dc9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/obesity-diabetes-treatments-fuel-eli-143912326.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/obesity-diabetes-treatments-fuel-eli-143912326.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T14:38:00+00:00",
    "headline": "Pre-markets Down on Questions: Fed, Jobs & Q3 Earnings",
    "summary": "Weekly Jobless Claims are not out again this Thursday morning, for the fifth straight week.",
    "url": "https://finance.yahoo.com/news/pre-markets-down-questions-fed-143800999.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "2b67718a-5957-3615-901d-3ec39e308d7d",
      "content": {
        "id": "2b67718a-5957-3615-901d-3ec39e308d7d",
        "contentType": "STORY",
        "title": "Pre-markets Down on Questions: Fed, Jobs & Q3 Earnings",
        "description": "",
        "summary": "Weekly Jobless Claims are not out again this Thursday morning, for the fifth straight week.",
        "pubDate": "2025-10-30T14:38:00Z",
        "displayTime": "2025-10-30T14:38:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/6595e07b346b4000ca3849b1a71f528e",
          "originalWidth": 620,
          "originalHeight": 397,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jjfSANH5QQMQwsHfM1IYGw--~B/aD0zOTc7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/6595e07b346b4000ca3849b1a71f528e.cf.webp",
              "width": 620,
              "height": 397,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Cb339LHHVUCvHzjRwa8Mug--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/6595e07b346b4000ca3849b1a71f528e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pre-markets-down-questions-fed-143800999.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pre-markets-down-questions-fed-143800999.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EL"
            },
            {
              "symbol": "MA"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T14:30:03+00:00",
    "headline": "Compared to Estimates, Lilly (LLY) Q3 Earnings: A Look at Key Metrics",
    "summary": "The headline numbers for Lilly (LLY) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
    "url": "https://finance.yahoo.com/news/compared-estimates-lilly-lly-q3-143003924.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "784c274c-6621-3833-86e2-67355f8a82eb",
      "content": {
        "id": "784c274c-6621-3833-86e2-67355f8a82eb",
        "contentType": "STORY",
        "title": "Compared to Estimates, Lilly (LLY) Q3 Earnings: A Look at Key Metrics",
        "description": "",
        "summary": "The headline numbers for Lilly (LLY) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
        "pubDate": "2025-10-30T14:30:03Z",
        "displayTime": "2025-10-30T14:30:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/105b2acef7bf0873f24b78932b1fdc3c",
          "originalWidth": 900,
          "originalHeight": 675,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5VYVrk.dAWOtAbYePjBVnw--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/105b2acef7bf0873f24b78932b1fdc3c.cf.webp",
              "width": 900,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bx6KQdkgJ6y2nL6XqljE4w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/105b2acef7bf0873f24b78932b1fdc3c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/compared-estimates-lilly-lly-q3-143003924.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/compared-estimates-lilly-lly-q3-143003924.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T14:25:52+00:00",
    "headline": "Eli Lilly Blows Away Q3 Earnings Expectations",
    "summary": "Eli Lilly (NYSE: LLY) delivered a commanding third quarter, posting earnings and revenue that significantly exceeded expectations while raising full-year guidance. The stock traded at $854.08 following the pre-market release, reflecting investor confidence in the company’s accelerating momentum across its core portfolio. Incretin Dominance Reshapes the Quarter Lilly’s incretin drugs drove the earnings beat. Mounjaro, ... Eli Lilly Blows Away Q3 Earnings Expectations",
    "url": "https://247wallst.com/investing/2025/10/30/eli-lilly-blows-away-q3-earnings-expectations/",
    "source": "24/7 Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "c2adc109-f5ea-33c6-9aed-6e4804630de0",
      "content": {
        "id": "c2adc109-f5ea-33c6-9aed-6e4804630de0",
        "contentType": "STORY",
        "title": "Eli Lilly Blows Away Q3 Earnings Expectations",
        "description": "",
        "summary": "Eli Lilly (NYSE: LLY) delivered a commanding third quarter, posting earnings and revenue that significantly exceeded expectations while raising full-year guidance. The stock traded at $854.08 following the pre-market release, reflecting investor confidence in the company’s accelerating momentum across its core portfolio. Incretin Dominance Reshapes the Quarter Lilly’s incretin drugs drove the earnings beat. Mounjaro, ... Eli Lilly Blows Away Q3 Earnings Expectations",
        "pubDate": "2025-10-30T14:25:52Z",
        "displayTime": "2025-10-30T14:25:52Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/24_7_wall_st__718/9fec819aa20ef9e5ca12ffbeabcc0431",
          "originalWidth": 1366,
          "originalHeight": 767,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lLLSB_dvHOZt9LeIdTXAPw--~B/aD03Njc7dz0xMzY2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/24_7_wall_st__718/9fec819aa20ef9e5ca12ffbeabcc0431.cf.webp",
              "width": 1366,
              "height": 767,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/D2kRvsgJO9CzOGb_dV46sQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/24_7_wall_st__718/9fec819aa20ef9e5ca12ffbeabcc0431.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "24/7 Wall St.",
          "url": "https://247wallst.com/"
        },
        "canonicalUrl": {
          "url": "https://247wallst.com/investing/2025/10/30/eli-lilly-blows-away-q3-earnings-expectations/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-blows-away-q3-142552875.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T14:08:39+00:00",
    "headline": "AI boom drives trillion-dollar tech valuations and record bets on chipmakers",
    "summary": "Nvidia’s shares jumped nearly 11% over the past month, adding about $500 billion in market value as it became the first company to reach a $5 trillion valuation.  Chief Executive Jensen Huang this week announced $500 billion in AI chip orders and plans to build seven supercomputers for the U.S. government.  Broadcom gained 17% over the past month to reach a $1.82 trillion valuation, while TSMC added 15% to $1.28 trillion and Alphabet climbed 13% to $3.32 trillion.",
    "url": "https://finance.yahoo.com/news/ai-boom-drives-trillion-dollar-140839736.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "708d5c98-dbe0-3bec-8cf6-c9549b944385",
      "content": {
        "id": "708d5c98-dbe0-3bec-8cf6-c9549b944385",
        "contentType": "STORY",
        "title": "AI boom drives trillion-dollar tech valuations and record bets on chipmakers",
        "description": "",
        "summary": "Nvidia’s shares jumped nearly 11% over the past month, adding about $500 billion in market value as it became the first company to reach a $5 trillion valuation.  Chief Executive Jensen Huang this week announced $500 billion in AI chip orders and plans to build seven supercomputers for the U.S. government.  Broadcom gained 17% over the past month to reach a $1.82 trillion valuation, while TSMC added 15% to $1.28 trillion and Alphabet climbed 13% to $3.32 trillion.",
        "pubDate": "2025-10-30T14:08:39Z",
        "displayTime": "2025-10-30T14:08:39Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters-finance.com/e461575d9f26c4c82821bff927ab972d",
          "originalWidth": 800,
          "originalHeight": 534,
          "caption": "FILE PHOTO: Illustration shows AI (Artificial Intelligence) letters and robot hand",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZmmCfHs15OTzCtS7LTDW.g--~B/aD01MzQ7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters-finance.com/e461575d9f26c4c82821bff927ab972d.cf.webp",
              "width": 800,
              "height": 534,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Z4B2DfgAJCa73A5u20v11Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters-finance.com/e461575d9f26c4c82821bff927ab972d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "http://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ai-boom-drives-trillion-dollar-140839736.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ai-boom-drives-trillion-dollar-140839736.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "AAPL"
            },
            {
              "symbol": "OPAI.PVT"
            },
            {
              "symbol": "ORCL"
            },
            {
              "symbol": "NOKIA.HE"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "AVGO"
            },
            {
              "symbol": "2330.TW"
            },
            {
              "symbol": "GOOGL"
            },
            {
              "symbol": "0700.HK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T13:25:32+00:00",
    "headline": "Sector Update: Health Care Stocks Flat to Higher Premarket Thursday",
    "summary": "Health care stocks were flat to higher premarket Thursday, with the iShares Biotechnology ETF (IBB)",
    "url": "https://finance.yahoo.com/news/sector-health-care-stocks-flat-132532791.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "0a3af45f-6131-3599-8391-6bcda45d2fee",
      "content": {
        "id": "0a3af45f-6131-3599-8391-6bcda45d2fee",
        "contentType": "STORY",
        "title": "Sector Update: Health Care Stocks Flat to Higher Premarket Thursday",
        "description": "",
        "summary": "Health care stocks were flat to higher premarket Thursday, with the iShares Biotechnology ETF (IBB)",
        "pubDate": "2025-10-30T13:25:32Z",
        "displayTime": "2025-10-30T13:25:32Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-flat-132532791.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-flat-132532791.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "4523.T"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T13:25:30+00:00",
    "headline": "Novo Nordisk's bid for Metsera, Eli Lilly boosts revenue outlook",
    "summary": "Morning Brief host Julie Hyman tracks several of the day's top trending stock tickers, including Novo Nordisk's (NVO) bidding war with Pfizer (PFE) over who acquires Metsera (MTSR), Merck (MRK) cutting the higher end of its sales guidance, and Eli Lilly (LLY) raising its full-year revenue forecast after topping third quarter earnings estimates. To watch more expert insights and analysis on the latest market action, check out more&nbsp;Morning Brief.",
    "url": "https://finance.yahoo.com/video/novo-nordisks-bid-metsera-eli-132530876.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "53ad808d-0a64-316e-b904-5fadedc43296",
      "content": {
        "id": "53ad808d-0a64-316e-b904-5fadedc43296",
        "contentType": "VIDEO",
        "title": "Novo Nordisk's bid for Metsera, Eli Lilly boosts revenue outlook",
        "description": "<p>Morning Brief host <a data-i13n=\"cpos:1;pos:1\" href=\"https://www.yahoo.com/author/julie-hyman/?.tsrc=fin-srch\">Julie Hyman</a> tracks several of the day's top trending stock tickers, including Novo Nordisk's (<a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/quote/NVO\">NVO</a>) bidding war with Pfizer (<a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/quote/PFE\">PFE</a>) over who acquires Metsera (<a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/quote/MTSR\">MTSR</a>), Merck (<a data-i13n=\"cpos:5;pos:1\" href=\"https://finance.yahoo.com/quote/MRK\">MRK</a>) cutting the higher end of its sales guidance, and Eli Lilly (<a data-i13n=\"cpos:6;pos:1\" href=\"https://finance.yahoo.com/quote/LLY\">LLY</a>) raising its full-year revenue forecast after topping third quarter earnings estimates.</p>\n<p>To watch more expert insights and analysis on the latest market action, check out more <a data-i13n=\"cpos:7;pos:1\" href=\"https://finance.yahoo.com/videos/series/morning-brief/\">Morning Brief</a>.</p>",
        "summary": "Morning Brief host Julie Hyman tracks several of the day's top trending stock tickers, including Novo Nordisk's (NVO) bidding war with Pfizer (PFE) over who acquires Metsera (MTSR), Merck (MRK) cutting the higher end of its sales guidance, and Eli Lilly (LLY) raising its full-year revenue forecast after topping third quarter earnings estimates. To watch more expert insights and analysis on the latest market action, check out more&nbsp;Morning Brief.",
        "pubDate": "2025-10-30T13:25:30Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-10/c3bcddc0-b593-11f0-bc5f-f57782aa946e",
          "originalWidth": 6000,
          "originalHeight": 3378,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YBu7Xn0iRDguTDKaEMSYTg--~B/aD0zMzc4O3c9NjAwMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-10/c3bcddc0-b593-11f0-bc5f-f57782aa946e.cf.webp",
              "width": 6000,
              "height": 3378,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QguyyJjscckb7cimObETAA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-10/c3bcddc0-b593-11f0-bc5f-f57782aa946e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/novo-nordisks-bid-metsera-eli-132530876.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/novo-nordisks-bid-metsera-eli-132530876.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T13:22:00+00:00",
    "headline": "Eli Lilly Stock Rises on Earnings as Investors Await Trump Drug Pricing Deal",
    "summary": "The company posted adjusted earnings of $7.02 a share, compared with the $5.89 forecast by analysts, according to FactSet.  Lilly now says it expects non-GAAP earnings from $23 to $23.70 a share this year, up from $21.75 to $23.  The new guidance is well above the current analyst consensus estimate of $22.48, and suggests Wall Street’s fourth quarter expectations may be too low.",
    "url": "https://www.barrons.com/articles/eli-lilly-earnings-stock-price-99b5da9b?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "7a1a4872-7d20-39d1-97bb-202649749c10",
      "content": {
        "id": "7a1a4872-7d20-39d1-97bb-202649749c10",
        "contentType": "STORY",
        "title": "Eli Lilly Stock Rises on Earnings as Investors Await Trump Drug Pricing Deal",
        "description": "",
        "summary": "The company posted adjusted earnings of $7.02 a share, compared with the $5.89 forecast by analysts, according to FactSet.  Lilly now says it expects non-GAAP earnings from $23 to $23.70 a share this year, up from $21.75 to $23.  The new guidance is well above the current analyst consensus estimate of $22.48, and suggests Wall Street’s fourth quarter expectations may be too low.",
        "pubDate": "2025-10-30T13:22:00Z",
        "displayTime": "2025-10-30T13:22:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/7a1a4872-7d20-39d1-97bb-202649749c10/eli-lilly-stock-rises-on.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/8ef25f59da6d3b27743d6ebc7d88b9c8",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iym5uLzLGe9y99aj6gbFTw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/8ef25f59da6d3b27743d6ebc7d88b9c8.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/drwih53hfNYT5OPerS084w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/8ef25f59da6d3b27743d6ebc7d88b9c8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/eli-lilly-earnings-stock-price-99b5da9b?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "AZNCF"
            },
            {
              "symbol": "WMT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T13:09:33+00:00",
    "headline": "Eli Lilly Tops Earnings Forecasts and Raises Outlook as Zepbound and Mounjaro Sales Surge",
    "summary": "Strong demand for weight-loss and diabetes drugs boosts results and guidance.",
    "url": "https://finance.yahoo.com/news/eli-lilly-tops-earnings-forecasts-130933358.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "115288e8-3f38-3e04-a499-c8fce2b7412a",
      "content": {
        "id": "115288e8-3f38-3e04-a499-c8fce2b7412a",
        "contentType": "STORY",
        "title": "Eli Lilly Tops Earnings Forecasts and Raises Outlook as Zepbound and Mounjaro Sales Surge",
        "description": "",
        "summary": "Strong demand for weight-loss and diabetes drugs boosts results and guidance.",
        "pubDate": "2025-10-30T13:09:33Z",
        "displayTime": "2025-10-30T13:09:33Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/d0b2925021ba921981c34cbf188ac66c",
          "originalWidth": 500,
          "originalHeight": 500,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8b14zxH4BANQFraIfqB7ug--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/d0b2925021ba921981c34cbf188ac66c.cf.webp",
              "width": 500,
              "height": 500,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/j_oIKXponyFLhltsjvcwTQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/d0b2925021ba921981c34cbf188ac66c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-tops-earnings-forecasts-130933358.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-tops-earnings-forecasts-130933358.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T13:08:29+00:00",
    "headline": "Novo Nordisk A/S (NVO)’s Top Investor Decides to Take Control of its Board, Reports Reuters",
    "summary": "Novo Nordisk A/S (NYSE:NVO) is one of the Best Bargain Stocks to Buy in November. On October 22, Reuters reported that Novo Nordisk A/S (NYSE:NVO)’s top investor, the non-profit Novo Nordisk Foundation, decided to take control of the company’s board. It vowed a strong emphasis on the critical US market to fuel sales growth for Wegovy, and highlighted […]",
    "url": "https://finance.yahoo.com/news/novo-nordisk-nvo-top-investor-130829661.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "7bc3ea58-2410-3110-a9a4-8a084d178290",
      "content": {
        "id": "7bc3ea58-2410-3110-a9a4-8a084d178290",
        "contentType": "STORY",
        "title": "Novo Nordisk A/S (NVO)’s Top Investor Decides to Take Control of its Board, Reports Reuters",
        "description": "",
        "summary": "Novo Nordisk A/S (NYSE:NVO) is one of the Best Bargain Stocks to Buy in November. On October 22, Reuters reported that Novo Nordisk A/S (NYSE:NVO)’s top investor, the non-profit Novo Nordisk Foundation, decided to take control of the company’s board. It vowed a strong emphasis on the critical US market to fuel sales growth for Wegovy, and highlighted […]",
        "pubDate": "2025-10-30T13:08:29Z",
        "displayTime": "2025-10-30T13:08:29Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/6a3eb9e1b9760b4bed78b16d1253664c",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Novo Nordisk A/S (NVO)’s Top Investor Decides to Take Control of its Board, Reports Reuters ",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BmBW9k2APq04bcY0cbi9DA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/6a3eb9e1b9760b4bed78b16d1253664c.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/az9U5V8Z7oN9MQphgaNFnA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/6a3eb9e1b9760b4bed78b16d1253664c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-nvo-top-investor-130829661.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-nvo-top-investor-130829661.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T13:01:46+00:00",
    "headline": "Eli Lilly Raises 2025 Outlook as Third-Quarter Results Beat Estimates",
    "summary": "Eli Lilly (LLY) lifted its full-year outlook and reported third-quarter results above market expecta",
    "url": "https://finance.yahoo.com/news/eli-lilly-raises-2025-outlook-130146435.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "2fbde754-12b5-3e18-8037-272df98986e0",
      "content": {
        "id": "2fbde754-12b5-3e18-8037-272df98986e0",
        "contentType": "STORY",
        "title": "Eli Lilly Raises 2025 Outlook as Third-Quarter Results Beat Estimates",
        "description": "",
        "summary": "Eli Lilly (LLY) lifted its full-year outlook and reported third-quarter results above market expecta",
        "pubDate": "2025-10-30T13:01:46Z",
        "displayTime": "2025-10-30T13:01:46Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/6fcb0e4daa23894ba9c15e5da184e3ec",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "elililly - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YdChze6TwjaAcf9wQBVtXw--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/6fcb0e4daa23894ba9c15e5da184e3ec.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Lxi7q1ztTvSWKCYpfuiGyA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/6fcb0e4daa23894ba9c15e5da184e3ec.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-raises-2025-outlook-130146435.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-raises-2025-outlook-130146435.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T12:34:15+00:00",
    "headline": "5 Things to Know Before the Stock Market Opens",
    "summary": "News of the day for Oct. 30, 2025",
    "url": "https://www.investopedia.com/5-things-to-know-before-the-stock-market-opens-october-30-2025-11840105",
    "source": "Investopedia",
    "provider": "yfinance",
    "raw": {
      "id": "05302427-7532-3bb0-8b51-cfe6c0b98ab6",
      "content": {
        "id": "05302427-7532-3bb0-8b51-cfe6c0b98ab6",
        "contentType": "STORY",
        "title": "5 Things to Know Before the Stock Market Opens",
        "description": "",
        "summary": "News of the day for Oct. 30, 2025",
        "pubDate": "2025-10-30T12:34:15Z",
        "displayTime": "2025-10-30T12:34:15Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/investopedia_245/e836f5bea04794eb7e7fed06c5386037",
          "originalWidth": 4000,
          "originalHeight": 2668,
          "caption": "Michael Nagle / Bloomberg / Getty Images Apple is set to release its quarterly results after the closing bell on Thursday.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YjL2ZRZcitwxbRVeAzvuFQ--~B/aD0yNjY4O3c9NDAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/investopedia_245/e836f5bea04794eb7e7fed06c5386037.cf.webp",
              "width": 4000,
              "height": 2668,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mZ7EhVXdSem4JaA3I1ezgw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/investopedia_245/e836f5bea04794eb7e7fed06c5386037.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investopedia",
          "url": "https://www.investopedia.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investopedia.com/5-things-to-know-before-the-stock-market-opens-october-30-2025-11840105",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/5-things-know-stock-market-123415464.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AAPL"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "GOOGL"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "META"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T12:20:17+00:00",
    "headline": "Novo Nordisk launches bidding war with Pfizer for obesity drugmaker Metsera",
    "summary": "Danish pharmaceutical giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy, announced Thursday an unsolicited bid to acquire obesity treatment maker Metsera, topping an offer from US rival Pfizer which called the move \"reckless\".Pfizer called Novo Nordisk's offer a \"reckless and unprecedented proposal\".",
    "url": "https://finance.yahoo.com/news/novo-nordisk-launches-bidding-war-122017670.html",
    "source": "AFP",
    "provider": "yfinance",
    "raw": {
      "id": "9a425d2a-9042-3432-9274-958580e54103",
      "content": {
        "id": "9a425d2a-9042-3432-9274-958580e54103",
        "contentType": "STORY",
        "title": "Novo Nordisk launches bidding war with Pfizer for obesity drugmaker Metsera",
        "description": "",
        "summary": "Danish pharmaceutical giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy, announced Thursday an unsolicited bid to acquire obesity treatment maker Metsera, topping an offer from US rival Pfizer which called the move \"reckless\".Pfizer called Novo Nordisk's offer a \"reckless and unprecedented proposal\". ",
        "pubDate": "2025-10-30T12:20:17Z",
        "displayTime": "2025-10-30T12:20:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/afp.com/9112c44e9674a319b58b5193b7a643c2",
          "originalWidth": 768,
          "originalHeight": 512,
          "caption": "Novo Nordisk, maker of Ozempic and Wegovy, made an offer valuing Metsera at $6 billion (Mads Claus Rasmussen)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/66kR0dV4VPhQeVkTZ33Rsw--~B/aD01MTI7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/afp.com/9112c44e9674a319b58b5193b7a643c2.cf.webp",
              "width": 768,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SrE8ol9j1ctunRbZo2eCUw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/afp.com/9112c44e9674a319b58b5193b7a643c2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "AFP",
          "url": "http://www.afp.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-launches-bidding-war-122017670.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-launches-bidding-war-122017670.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T11:57:00+00:00",
    "headline": "Mounjaro Powers Eli Lilly to Bumper Quarter of Earnings",
    "summary": "Eli Lilly reported higher profit and raised its outlook on surging demand for its weight-loss drugs, sending its shares higher.",
    "url": "https://www.wsj.com/health/pharma/eli-lilly-raises-outlook-on-soaring-glp-1-demand-18859a7a",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "3e4efaf5-f734-3c37-82ec-0bdeb1153ae9",
      "content": {
        "id": "3e4efaf5-f734-3c37-82ec-0bdeb1153ae9",
        "contentType": "STORY",
        "title": "Mounjaro Powers Eli Lilly to Bumper Quarter of Earnings",
        "description": "",
        "summary": "Eli Lilly reported higher profit and raised its outlook on surging demand for its weight-loss drugs, sending its shares higher.",
        "pubDate": "2025-10-30T11:57:00Z",
        "displayTime": "2025-10-30T11:57:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/the_wall_street_journal_hosted_996/ebfacf16128053b78e340a69bd6c6b19",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/r0iSMZZCtZn.dRkSis2EQA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_wall_street_journal_hosted_996/ebfacf16128053b78e340a69bd6c6b19.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/I5NOW0HbgCCDkUveX7rWxQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/the_wall_street_journal_hosted_996/ebfacf16128053b78e340a69bd6c6b19.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/eli-lilly-raises-outlook-on-soaring-glp-1-demand-18859a7a",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mounjaro-powers-eli-lilly-bumper-115700629.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T11:55:03+00:00",
    "headline": "Eli Lilly (LLY) Q3 Earnings and Revenues Surpass Estimates",
    "summary": "Lilly (LLY) delivered earnings and revenue surprises of +16.61% and +9.91%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finance.yahoo.com/news/eli-lilly-lly-q3-earnings-115503034.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "ab0d9ab9-5bff-364f-bc32-b31cf6d1a1ce",
      "content": {
        "id": "ab0d9ab9-5bff-364f-bc32-b31cf6d1a1ce",
        "contentType": "STORY",
        "title": "Eli Lilly (LLY) Q3 Earnings and Revenues Surpass Estimates",
        "description": "",
        "summary": "Lilly (LLY) delivered earnings and revenue surprises of +16.61% and +9.91%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?",
        "pubDate": "2025-10-30T11:55:03Z",
        "displayTime": "2025-10-30T11:55:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/c65fb4556b91b6c9dc83e4eff25fede0",
          "originalWidth": 3000,
          "originalHeight": 2351,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/22J0oUBDggIxRsu_SBEo3A--~B/aD0yMzUxO3c9MzAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/zacks.com/c65fb4556b91b6c9dc83e4eff25fede0.cf.webp",
              "width": 3000,
              "height": 2351,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/c871s3MwhyhBJ_fCBFL4cw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c65fb4556b91b6c9dc83e4eff25fede0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-lly-q3-earnings-115503034.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-lly-q3-earnings-115503034.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T11:51:35+00:00",
    "headline": "Eli Lilly ramps up orforglipron production with $1.2bn Puerto Rico site expansion",
    "summary": "The Puerto Rico facility investment comes alongside Lilly’s construction of four “mega sites” in the US.",
    "url": "https://www.pharmaceutical-technology.com/news/eli-lilly-ramps-up-orforglipron-production-with-1-2bn-puerto-rico-site-expansion/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "f6c3ceda-2f4a-354f-925e-f51705a2dca9",
      "content": {
        "id": "f6c3ceda-2f4a-354f-925e-f51705a2dca9",
        "contentType": "STORY",
        "title": "Eli Lilly ramps up orforglipron production with $1.2bn Puerto Rico site expansion",
        "description": "",
        "summary": "The Puerto Rico facility investment comes alongside Lilly’s construction of four “mega sites” in the US.",
        "pubDate": "2025-10-30T11:51:35Z",
        "displayTime": "2025-10-30T11:51:35Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/58ab51898bdf9df5df843b666a19d891",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w4ZZR0zFvvOSQxoyeN_hsg--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/58ab51898bdf9df5df843b666a19d891.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WNQRMeYy4ypgnySGYrlcew--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/58ab51898bdf9df5df843b666a19d891.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/eli-lilly-ramps-up-orforglipron-production-with-1-2bn-puerto-rico-site-expansion/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-ramps-orforglipron-production-115135212.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T11:47:10+00:00",
    "headline": "Stocks Fall Pre-Bell as Investors Assess Trump-Xi Meeting Outcome; Powell Casts Doubt on December Rate Cut",
    "summary": "US equity markets were tracking in the red before the opening bell Thursday as traders digest the ou",
    "url": "https://finance.yahoo.com/news/stocks-fall-pre-bell-investors-114710762.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "b7a00587-3ed6-3e4f-96ae-8f865db434e9",
      "content": {
        "id": "b7a00587-3ed6-3e4f-96ae-8f865db434e9",
        "contentType": "STORY",
        "title": "Stocks Fall Pre-Bell as Investors Assess Trump-Xi Meeting Outcome; Powell Casts Doubt on December Rate Cut",
        "description": "",
        "summary": "US equity markets were tracking in the red before the opening bell Thursday as traders digest the ou",
        "pubDate": "2025-10-30T11:47:10Z",
        "displayTime": "2025-10-30T11:47:10Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/ebc5b64c4dc98d6f607464cb4d50ba3d",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "stock trading floor NYSE market wall street  - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IeAizqJZBy9vwDXxekAvFA--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/ebc5b64c4dc98d6f607464cb4d50ba3d.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OyOVBGCbqGk3V7zjfLwvvA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/ebc5b64c4dc98d6f607464cb4d50ba3d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/stocks-fall-pre-bell-investors-114710762.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/stocks-fall-pre-bell-investors-114710762.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T11:22:35+00:00",
    "headline": "Eli Lilly raises annual revenue guidance amid strong weight-loss drug demand",
    "summary": "Investing.com - Eli Lilly has lifted its full-year financial forecasts, fueled by its mega-popular obesity treatments which helped the drugmaker deliver better-than-anticipated third-quarter results.",
    "url": "https://finance.yahoo.com/news/eli-lilly-raises-annual-revenue-112235192.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "58a15982-8585-31b5-90b7-35e3f9cb4c35",
      "content": {
        "id": "58a15982-8585-31b5-90b7-35e3f9cb4c35",
        "contentType": "STORY",
        "title": "Eli Lilly raises annual revenue guidance amid strong weight-loss drug demand",
        "description": "",
        "summary": "Investing.com - Eli Lilly has lifted its full-year financial forecasts, fueled by its mega-popular obesity treatments which helped the drugmaker deliver better-than-anticipated third-quarter results.",
        "pubDate": "2025-10-30T11:22:35Z",
        "displayTime": "2025-10-30T11:22:35Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-raises-annual-revenue-112235192.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-raises-annual-revenue-112235192.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T11:12:00+00:00",
    "headline": "Lilly hikes revenue forecasts on booming obesity drug sales",
    "summary": "Tirzepatide, which Lilly sells as Mounjaro for diabetes and Zepbound for obesity, topped $10 billion in the third-quarter, officially becoming the world’s best-selling drug.",
    "url": "https://www.biopharmadive.com/news/lilly-third-quarter-2025-earnings-zepbound-mounjaro-obesity-sales/804232/",
    "source": "BioPharma Dive",
    "provider": "yfinance",
    "raw": {
      "id": "7633a2c1-51ba-3254-8196-ea8d4c1cb181",
      "content": {
        "id": "7633a2c1-51ba-3254-8196-ea8d4c1cb181",
        "contentType": "STORY",
        "title": "Lilly hikes revenue forecasts on booming obesity drug sales",
        "description": "",
        "summary": "Tirzepatide, which Lilly sells as Mounjaro for diabetes and Zepbound for obesity, topped $10 billion in the third-quarter, officially becoming the world’s best-selling drug.",
        "pubDate": "2025-10-30T11:12:00Z",
        "displayTime": "2025-10-30T11:12:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/biopharma_dive_768/6946de5e036045dd23477b446c5c8749",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2SGFX.Dt94eavIAPzxsPsw--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/biopharma_dive_768/6946de5e036045dd23477b446c5c8749.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iNa9.b8FAEIMKgDsnRBkiQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/biopharma_dive_768/6946de5e036045dd23477b446c5c8749.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "BioPharma Dive",
          "url": "https://biopharmadive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.biopharmadive.com/news/lilly-third-quarter-2025-earnings-zepbound-mounjaro-obesity-sales/804232/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lilly-hikes-revenue-forecasts-booming-111200263.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T11:04:17+00:00",
    "headline": "Eli Lilly (NYSE:LLY) Delivers Strong Q3 Numbers, Stock Soars",
    "summary": "Global pharmaceutical company Eli Lilly (NYSE:LLY) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 53.9% year on year to $17.6 billion. The company’s full-year revenue guidance of $63.25 billion at the midpoint came in 2.6% above analysts’ estimates. Its non-GAAP profit of $7.02 per share was 18.6% above analysts’ consensus estimates.",
    "url": "https://finance.yahoo.com/news/eli-lilly-nyse-lly-delivers-110417091.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "432addde-6e45-3c47-aaca-d89d66280b46",
      "content": {
        "id": "432addde-6e45-3c47-aaca-d89d66280b46",
        "contentType": "STORY",
        "title": "Eli Lilly (NYSE:LLY) Delivers Strong Q3 Numbers, Stock Soars",
        "description": "",
        "summary": "Global pharmaceutical company Eli Lilly (NYSE:LLY) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 53.9% year on year to $17.6 billion. The company’s full-year revenue guidance of $63.25 billion at the midpoint came in 2.6% above analysts’ estimates. Its non-GAAP profit of $7.02 per share was 18.6% above analysts’ consensus estimates.",
        "pubDate": "2025-10-30T11:04:17Z",
        "displayTime": "2025-10-30T11:04:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/2d0b545c448821f8d1ada0dbe955b186",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "LLY Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/y7jUkGcVljBpqcrgSnimZQ--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/2d0b545c448821f8d1ada0dbe955b186.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fw6rZdJZ6CRFkLxhDmPhew--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/2d0b545c448821f8d1ada0dbe955b186.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-nyse-lly-delivers-110417091.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-nyse-lly-delivers-110417091.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T10:53:25+00:00",
    "headline": "Lilly: Q3 Earnings Snapshot",
    "summary": "INDIANAPOLIS (AP) — Eli Lilly and Co. (LLY) on Thursday reported third-quarter profit of $5.58 billion. The Indianapolis-based company said it had net income of $6.21 per share. Earnings, adjusted for one-time gains and costs, were $7.02 per share.",
    "url": "https://finance.yahoo.com/news/lilly-q3-earnings-snapshot-105325007.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "020d356a-09ca-32b1-b3d3-e7beae550f52",
      "content": {
        "id": "020d356a-09ca-32b1-b3d3-e7beae550f52",
        "contentType": "STORY",
        "title": "Lilly: Q3 Earnings Snapshot",
        "description": "",
        "summary": "INDIANAPOLIS (AP) — Eli Lilly and Co. (LLY) on Thursday reported third-quarter profit of $5.58 billion. The Indianapolis-based company said it had net income of $6.21 per share. Earnings, adjusted for one-time gains and costs, were $7.02 per share.",
        "pubDate": "2025-10-30T10:53:25Z",
        "displayTime": "2025-10-30T10:53:25Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/lilly-q3-earnings-snapshot-105325007.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lilly-q3-earnings-snapshot-105325007.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T10:45:00+00:00",
    "headline": "Lilly reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidance",
    "summary": "Eli Lilly and Company (NYSE: LLY) today announced its financial results for the third-quarter of 2025.",
    "url": "https://finance.yahoo.com/news/lilly-reports-third-quarter-2025-104500744.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "d9e2fb90-fbb7-3ffe-ab72-f9379e6f8353",
      "content": {
        "id": "d9e2fb90-fbb7-3ffe-ab72-f9379e6f8353",
        "contentType": "STORY",
        "title": "Lilly reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidance",
        "description": "",
        "summary": "Eli Lilly and Company (NYSE: LLY) today announced its financial results for the third-quarter of 2025.",
        "pubDate": "2025-10-30T10:45:00Z",
        "displayTime": "2025-10-30T10:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/f3aaa8410f59c3eccd5d187ecffbd6ee",
          "originalWidth": 400,
          "originalHeight": 219,
          "caption": "Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7Y1fhfHoGbpYMTG8q90VAg--~B/aD0yMTk7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f3aaa8410f59c3eccd5d187ecffbd6ee.cf.webp",
              "width": 400,
              "height": 219,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.Goic7S8PJ1_UseTWpNhHw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f3aaa8410f59c3eccd5d187ecffbd6ee.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/lilly-reports-third-quarter-2025-104500744.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lilly-reports-third-quarter-2025-104500744.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "VERV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T10:32:17+00:00",
    "headline": "Pfizer and Roche place $10bn bets on obesity and liver disease therapies as Trump tightens grip on drug pricing and manufacturing",
    "summary": "The deals come against a backdrop of sweeping trade and pricing policies from Trump’s administration.",
    "url": "https://www.pharmaceutical-technology.com/analyst-comment/pfizer-roche-place-10bn-bets-obesity-liver-disease-therapies-trump-grip-drug-pricing-manufacturing/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "4b4127aa-43c8-3bed-be39-325c4076b133",
      "content": {
        "id": "4b4127aa-43c8-3bed-be39-325c4076b133",
        "contentType": "STORY",
        "title": "Pfizer and Roche place $10bn bets on obesity and liver disease therapies as Trump tightens grip on drug pricing and manufacturing",
        "description": "",
        "summary": "The deals come against a backdrop of sweeping trade and pricing policies from Trump’s administration.",
        "pubDate": "2025-10-30T10:32:17Z",
        "displayTime": "2025-10-30T10:32:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/0e7544e13aa84916ea5b32492fdca196",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "The battle for next-generation obesity and liver disease drugs is playing out on two fronts. Credit: crystal light/Shutterstock.com.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yFauHdEQIkRQ3U8fYYak_w--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/0e7544e13aa84916ea5b32492fdca196.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Efcy4FkSZVMlUCXEMasaCA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/0e7544e13aa84916ea5b32492fdca196.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/analyst-comment/pfizer-roche-place-10bn-bets-obesity-liver-disease-therapies-trump-grip-drug-pricing-manufacturing/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-roche-place-10bn-bets-103217867.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "ROG.SW"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T10:30:00+00:00",
    "headline": "Wall Street GOAT: Nvidia Rides Deal Bonanza to $5 Trillion Market Cap",
    "summary": "The White House hinted early Wednesday morning that Nvidia may regain greater access to the massive Chinese market.",
    "url": "https://www.thedailyupside.com/technology/artificial-intelligence/nvidia-rides-great-news-to-a-5-trilion-market-cap/",
    "source": "The Daily Upside",
    "provider": "yfinance",
    "raw": {
      "id": "3a88d58c-197c-33f5-ab33-37b8de1405b2",
      "content": {
        "id": "3a88d58c-197c-33f5-ab33-37b8de1405b2",
        "contentType": "STORY",
        "title": "Wall Street GOAT: Nvidia Rides Deal Bonanza to $5 Trillion Market Cap",
        "description": "",
        "summary": "The White House hinted early Wednesday morning that Nvidia may regain greater access to the massive Chinese market.",
        "pubDate": "2025-10-30T10:30:00Z",
        "displayTime": "2025-10-30T10:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/the_daily_upside_435/ada3eaf30de24f6d41bcef4548b78a17",
          "originalWidth": 1600,
          "originalHeight": 901,
          "caption": "Nvidia CEO Jensen Huang, wearing his trademark black leather jacket, is seen addressing a crowd on stage.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7QiwIxlIc8sU7so8AXmDtA--~B/aD05MDE7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_daily_upside_435/ada3eaf30de24f6d41bcef4548b78a17.cf.webp",
              "width": 1600,
              "height": 901,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/N5GP.7lPhLUE.qszLk9.Dw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/the_daily_upside_435/ada3eaf30de24f6d41bcef4548b78a17.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Daily Upside",
          "url": "http://thedailyupside.com/"
        },
        "canonicalUrl": {
          "url": "https://www.thedailyupside.com/technology/artificial-intelligence/nvidia-rides-great-news-to-a-5-trilion-market-cap/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/wall-street-goat-nvidia-rides-103000293.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "AAPL"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "META"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T10:30:00+00:00",
    "headline": "Fiserv Loses Nearly Half Its Market Cap After ‘Abysmal’ Quarter",
    "summary": "CEO Mike Lyons said on an earnings call that Argentina’s floundering economy was the major culprit for the company's woes.",
    "url": "https://www.thedailyupside.com/finance/fiserv-defies-wall-streets-comprehension-with-a-shockingly-bad-quarter/",
    "source": "The Daily Upside",
    "provider": "yfinance",
    "raw": {
      "id": "442f1351-0d5c-3edd-b090-daf313e1f020",
      "content": {
        "id": "442f1351-0d5c-3edd-b090-daf313e1f020",
        "contentType": "STORY",
        "title": "Fiserv Loses Nearly Half Its Market Cap After ‘Abysmal’ Quarter",
        "description": "",
        "summary": "CEO Mike Lyons said on an earnings call that Argentina’s floundering economy was the major culprit for the company's woes.",
        "pubDate": "2025-10-30T10:30:00Z",
        "displayTime": "2025-10-30T10:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/the_daily_upside_435/e189125240e008dc0e0a5f7b03d0f529",
          "originalWidth": 1600,
          "originalHeight": 901,
          "caption": "The exterior of a Fiserv office with the company's letter text logo is shown.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZT86PhvLhZ48FGjUdUzv0A--~B/aD05MDE7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_daily_upside_435/e189125240e008dc0e0a5f7b03d0f529.cf.webp",
              "width": 1600,
              "height": 901,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UvKSe.fIGoRyTA8hUeeqbg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/the_daily_upside_435/e189125240e008dc0e0a5f7b03d0f529.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Daily Upside",
          "url": "http://thedailyupside.com/"
        },
        "canonicalUrl": {
          "url": "https://www.thedailyupside.com/finance/fiserv-defies-wall-streets-comprehension-with-a-shockingly-bad-quarter/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fiserv-loses-nearly-half-market-103000766.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "FI"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T09:47:33+00:00",
    "headline": "Amazon, Apple Earnings, ECB Rate Decision: Still to Come This Week",
    "summary": "Investors will tune into earnings from Amazon and Apple, plus the European Central Bank's interest-rate decision. Here’s what to watch for: Today  Earnings: Amazon, Apple, Eli Lilly, Hershey, Mastercard   Federal Reserve speaker: Vice Chair for Supervision Michelle Bowman at 9:55 a.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-10-30-2025/card/amazon-apple-earnings-ecb-rate-decision-still-to-come-this-week-1blSVYxVeICJiLXieUbV?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "6c9908a2-8022-32d8-b3a9-960df20d3e18",
      "content": {
        "id": "6c9908a2-8022-32d8-b3a9-960df20d3e18",
        "contentType": "STORY",
        "title": "Amazon, Apple Earnings, ECB Rate Decision: Still to Come This Week",
        "description": "",
        "summary": "Investors will tune into earnings from Amazon and Apple, plus the European Central Bank's interest-rate decision. Here’s what to watch for: Today  Earnings: Amazon, Apple, Eli Lilly, Hershey, Mastercard   Federal Reserve speaker: Vice Chair for Supervision Michelle Bowman at 9:55 a.",
        "pubDate": "2025-10-30T09:47:33Z",
        "displayTime": "2025-10-30T09:47:33Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/6c9908a2-8022-32d8-b3a9-960df20d3e18/amazon-apple-earnings-ecb.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/9c793f7bc1cdfe14421ffe94f785de1b",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VEn4dzfDEOUCxLTPjR98hg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/9c793f7bc1cdfe14421ffe94f785de1b.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2fhvZvYKSpZAA5QAoyqtwQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/9c793f7bc1cdfe14421ffe94f785de1b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-10-30-2025/card/amazon-apple-earnings-ecb-rate-decision-still-to-come-this-week-1blSVYxVeICJiLXieUbV?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "AAPL"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "HSY"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "CVX"
            },
            {
              "symbol": "CL"
            },
            {
              "symbol": "XOM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]